Publications

Title

Author

Year

Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.

Tientcheu, LD; Bell, A; Secka, O; Ayorinde, A; Otu, J; Garton, NJ; Sutherland, JS; Ota, MO; ANTONIO, M; DOCKRELL, HM; KAMPMANN, B; Barer, MR;

2016

International journal of mycobacteriology, (2016).5 Supp Suppl 10.1016/j.ijmyco.2016.09.033.

Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa.

KARAT, AS; Omar, T; Von Gottberg, A; Tlali, M; Chihota, VN; CHURCHYARD, GJ; FIELDING, KL; Johnson, S; Martinson, NA; McCarthy, K; Wolter, N; Wong, EB; Charalambous, S; GRANT, AD;

2016

PloS one, (2016).11 11 10.1371/journal.pone.0166158.

Predicting tuberculosis risk.

Kik, SV; Cobelens, F; MOORE, D;

2016

Lancet, (2016).388 10057 10.1016/S0140-6736(16)32070-0.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre, F; Otu, J; Kendall, L; Forson, A; Kwara, A; Kudzawu, S; Kehinde, AO; Adebiyi, O; Salako, K; Baldeh, I; Jallow, A; Jallow, M; Dagnra, A; Dissé, K; Kadanga, EA; Idigbe, EO; Onubogu, C; Onyejepu, N; Gaye-Diallo, A; Ba-Diallo, A; Rabna, P; Mane, M; Sanogo, M; Diarra, B; Dezemon, Z; ... ANTONIO, M.

2016

BMC medicine, (2016).14 1 10.1186/s12916-016-0704-5.

The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.

RHODES, SJ; ZELMER, A; KNIGHT, GM; PRABOWO, SA; STOCKDALE, L; Evans, TG; Lindenstrøm, T; WHITE, RG; FLETCHER, H;

2016

Vaccine, (2016).34 50 10.1016/j.vaccine.2016.10.060.

Cohort Profile: The Kilifi Vaccine Monitoring Study.

ADETIFA, IM O; Bwanaali, T; Wafula, J; Mutuku, A; Karia, B; Makumi, A; Mwatsuma, P; Bauni, E; Hammitt, LL; Nokes, DJ; Maree, E; Tabu, C; Kamau, T; Mataza, C; Williams, TN; SCOTT, JA G;

2016

International journal of epidemiology, (2016).46 3 10.1093/ije/dyw202.

Tuberculosis.

Barry, RB; Atun, R; Cohen, T; Dye, C; Fraser, H; Gomez, GB; Knight, G; Murray, M; Nardell, E; Rubin, E; Salomon, J; VASSALL, A; Volchenkov, G; WHITE, R; Wilson, D; Yadav, P;

2016

Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases , The World Bank (2016).

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

HOUBEN, RM G J; Dodd, PJ;

2016

PLoS medicine, (2016).13 10 10.1371/journal.pmed.1002152.

Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.

Dudley, MZ; Sheen, P; Gilman, RH; Ticona, E; Friedland, JS; Kirwan, DE; Caviedes, L; Rodriguez, R; Cabrera, LZ; Coronel, J; Grandjean, L; MOORE, DA J; Evans, CA; Huaroto, L; Chávez-Pérez, V; Zimic, M;

2016

The American journal of tropical medicine and hygiene, (2016).95 6 10.4269/ajtmh.15-0711.

No added value of interferon-γ release to a prediction model for childhood tuberculosis.

TOGUN, TO; Egere, U; Gomez, MP; Sillah, AK; Daramy, M; TIENTCHEU, LD; S Sutherland, J; Hill, PC; KAMPMANN, B;

2016

The European respiratory journal, (2016).47 1 10.1183/13993003.00890-2015.